ImmunityBio
IBRX
IBRX
191 hedge funds and large institutions have $390M invested in ImmunityBio in 2024 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 61 increasing their positions, 46 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
191
Holders Change
+28
Holders Change %
+17.18%
% of All Funds
2.78%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
51
Increased
61
Reduced
46
Closed
21
Calls
$24.8M
Puts
$35.9M
Net Calls
-$11.1M
Net Calls Change
-$13.2M
Top Buyers
| 1 |
1
Jane Street
New York
|
$10.8M |
| 2 |
2
UBS AM
Chicago,
Illinois
|
$9.97M |
| 3 |
3
BlackRock
New York
|
$72.2M |
| 4 |
4
First Trust Advisors
Wheaton,
Illinois
|
$5.61M |
| 5 |
AWM
5
Accurate Wealth Management
Wesley Chapel,
Florida
|
$3.56M |
Top Sellers
| 1 |
1
State Street
Boston,
Massachusetts
|
$49.7M |
| 2 |
2
Invesco
Atlanta,
Georgia
|
$386K |
| 3 |
3
Citigroup
New York
|
$689K |
| 4 |
PA
4
Perceptive Advisors
New York
|
$0 |
| 5 |
5
Rafferty Asset Management
New York
|
$2.75M |
